title: Maternal diet supplemented with methyl-donors protects against atherosclerosis in F1 ApoE(-/-) mice.
abstract: Atherosclerosis is an inflammatory condition of the arterial wall mediated by cells of both innate and adaptive immunity. T lymphocytes play an important role in orchestrating the pathogenic immune response involved in the acceleration of atherosclerosis. Previously, we have shown that a prenatal methyl-donor supplementation diet (MS), when fed to dams during pregnancy and lactation, decreased the T cell-mediated pro-inflammatory cytokine and chemokine response in F1 mice. In the current study, we report feeding Apolipoprotein E (ApoE(-/-)) deficient dams with the MS diet during pregnancy reduces atherosclerotic plaques in F1 mice that were fed high fat diet (HFD) after weaning. F1 mice from dams on the MS diet exhibited increased global T cell DNA methylation. T-cell chemokines and their receptors (in particular CCR2, CCR5, and CXCR3) play important roles in the inflammatory cell recruitment to vascular lesions. MS diet significantly reduced Ccr2 mRNA and protein expression in CD3+ T cells but not in CD11b+ monocytes in MS F1 mice relative to controls. F1 litter size, HFD consumption, body weight, and body fat were similar between control and MS diet groups. Moreover, serum thiol metabolite levels were similar between the two groups. However, MS diet is associated with significantly higher serum HDL and lower LDL+VLDL levels in comparison to F1 mice from dams on the control diet. Inflammatory cytokines (IL-17, TNF-α, IL-6) were also lower in MS F1 mice serum and conditioned media from T-cell culture. Altogether, these data suggest that the MS diet ameliorates development of atherosclerosis by inhibiting the T-cell Ccr2 expression, reducing inflammatory cytokines production and increasing serum HDL:LDL ratio.
authors: Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
authors: Colin
authors: C
authors: Delaney
authors: Sanjay K
authors: SK
authors: Garg
authors: Chris
authors: C
authors: Fernandes
authors: Mark
authors: M
authors: Hoeltzel
authors: Robert H
authors: RH
authors: Allen
authors: Sally
authors: S
authors: Stabler
authors: Raymond
authors: R
authors: Yung
mesh_terms: D000818:Animals; D001011:Aorta / Q000473:pathology; D001057:Apolipoproteins E / Q000172:deficiency* / Q000378:metabolism; D050197:Atherosclerosis / Q000097:blood / Q000473:pathology / Q000517:prevention & control*; D001823:Body Composition; D002784:Cholesterol / Q000096:biosynthesis; D003433:Crosses, Genetic; D004032:Diet; D059305:Diet, High-Fat; D019587:Dietary Supplements; D005247:Feeding Behavior; D005260:Female; D005786:Gene Expression Regulation; D018836:Inflammation Mediators / Q000378:metabolism; D008074:Lipoproteins / Q000097:blood; D008098:Litter Size; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D008745:Methylation; D051379:Mice; D009000:Monocytes / Q000378:metabolism; D054390:Receptors, CCR2 / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013601:T-Lymphocytes / Q000378:metabolism; D015430:Weight Gain
chemical_list: D001057:Apolipoproteins E; C515335:Ccr2 protein, mouse; D018836:Inflammation Mediators; D008074:Lipoproteins; D054390:Receptors, CCR2; D013438:Sulfhydryl Compounds; D002784:Cholesterol